House Republicans allege CMS overreach in 'experiments'

In a letter to CMS Acting Administrator Andy Slavitt and Deputy Administrator and CMO Patrick Conway, a group of 179 members of the U.S. House of Representatives said CMS's Center for Medicare & Medicaid Innovation (CMMI) has "exceeded its authority, failed to engage stakeholders, and has upset the balance of power between the legislative and executive branches."

The letter cites three large-scale experiments proposed in the past two years by CMMI: the planned value-based Part B drug purchasing project, and the proposed bundled payment models for joint replacement and severe cardiac conditions. ...